bachlor 125 sc suspensionskoncentrat
aako danmark aps - epoxiconazol - suspensionskoncentrat - 125 g/l epoxiconazol
riza olie i vand emulsion
fmc agricultural solutions a/s (tidligere: cheminova a/s) - tebuconazol - olie i vand emulsion - 250 g/l tebuconazol
tebusha 25% ew olie i vand emulsion
sharda europe b.v.b.a. - tebuconazol - olie i vand emulsion - 250 g/l tebuconazol
agros c extra flydende bejdse
agros - difenoconazol, fludioxonil - flydende bejdse - 25 g/l difenoconazol ; 25 g/l fludioxonil
agros pro c extra flydende bejdse
agros pro - difenoconazol, fludioxonil - flydende bejdse - 25 g/l difenoconazol ; 25 g/l fludioxonil
difend extra flydende bejdse
globachem nv - difenoconazol, fludioxonil - flydende bejdse - 25 g/l difenoconazol ; 25 g/l fludioxonil
parsabiv
amgen europe b.v. - etelcalcetidhydrochlorid - hyperparathyroidisme, sekundær - anti-parathyroid agents, calcium homeostasis - parsabiv er indiceret til behandling af sekundær hyperparathyroidisme (shpt) hos voksne patienter med kronisk nyresygdom (ckd) ved hæmodialyse terapi.
bemfola
gedeon richter plc. - follitropin alfa - anovulation - køn hormoner og modulatorer af den genitale system, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. i kliniske forsøg skal disse patienter blev defineret ved en endogen serum lh niveau < 1. 2 ie / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotiske midler - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
clopidogrel acino pharma
acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antitrombotiske midler - clopidogrel er indiceret hos voksne til forebyggelse af atherothrombotic begivenheder i:patienter med myokardieinfarkt (fra få dage, indtil der er mindre end 35 dage), iskæmisk slagtilfælde (fra 7 dage indtil mindre end 6 måneder) eller etableret perifer arteriel sygdom. for yderligere oplysninger henvises der til afsnit 5.